Iron Triangle Partners LP's Q4 2022 13F: 9 new positions, 10 exits
Form 13F-HR for the quarter ended Dec 31, 2022 · filed Feb 14, 2023 · 26 reported positions · accession 0001172661-23-000991
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| New | UNIVERSAL HLTH SVCS INC (UHS) | — | 7.6% | +7.6 pts | +300K sh | new |
| New | COOPER COS INC (COO) | — | 7.3% | +7.3 pts | +123K sh | new |
| New | GILEAD SCIENCES INC (GILD) | — | 5.7% | +5.7 pts | +374K sh | new |
| Reduced | NEUROCRINE BIOSCIENCES INC (NBIX) | 6.6% | 2.1% | −4.5 pts | −256K sh | −72% |
| Exited | HEALTHEQUITY INC (HQY) | 5.2% | — | −5.2 pts | −440K sh | −100% |
| Reduced | CIGNA CORP NEW (CI) | 6.9% | 3.6% | −3.4 pts | −83,010 sh | −58% |
| Increased | ICON PLC (ICLR) | 2.7% | 7.8% | +5.1 pts | +141K sh | +169% |
| Exited | GUARDANT HEALTH INC (GH) | 4.6% | — | −4.6 pts | −487K sh | −100% |
| Exited | HCA HEALTHCARE INC (HCA) | 4.5% | — | −4.5 pts | −140K sh | −100% |
| Increased | SURGERY PARTNERS INC (SGRY) | 2.2% | 6.4% | +4.1 pts | +730K sh | +133% |
| Exited | BIO RAD LABS INC (BIO) | 3.6% | — | −3.6 pts | −50,000 sh | −100% |
| New | UNITED THERAPEUTICS CORP DEL (UTHR) | — | 3.6% | +3.6 pts | +71,576 sh | new |
| New | INTUITIVE SURGICAL INC (ISRG) | — | 3.3% | +3.3 pts | +70,000 sh | new |
| Exited | INSULET CORP (PODD) | 3.2% | — | −3.2 pts | −80,000 sh | −100% |
| Exited | CATALENT INC (CTLT) | 3.2% | — | −3.2 pts | −250K sh | −100% |
| Exited | HUMANA INC (HUM) | 3.0% | — | −3.0 pts | −35,000 sh | −100% |
| Exited | HORIZON THERAPEUTICS PUB L (HZNP) | 2.9% | — | −2.9 pts | −265K sh | −100% |
| Exited | ALNYLAM PHARMACEUTICALS INC (ALNY) | 2.8% | — | −2.8 pts | −80,000 sh | −100% |
| Increased | REPLIGEN CORP (RGEN) | 3.3% | 5.4% | +2.1 pts | +78,000 sh | +78% |
| Reduced | ACADIA HEALTHCARE COMPANY IN (ACHC) | 4.8% | 3.0% | −1.8 pts | −150K sh | −43% |
| Reduced | SANOFI (SNY) | 6.0% | 5.6% | −0.3 pts | −250K sh | −28% |
| Reduced | PACIFIC BIOSCIENCES CALIF IN (PACB) | 3.0% | 2.5% | −0.6 pts | −1.3M sh | −43% |
| Exited | ORION ACQUISITION CORP (OHPAU) | 1.7% | — | −1.7 pts | −1000K sh | −100% |
| New | SYNDAX PHARMACEUTICALS INC (SNDX) | — | 1.7% | +1.7 pts | +370K sh | new |
| New | AMYLYX PHARMACEUTICALS INC (AMLX) | — | 1.6% | +1.6 pts | +240K sh | new |
| New | PROMETHEUS BIOSCIENCES INC (RXDX) | — | 1.5% | +1.5 pts | +75,000 sh | new |
| Reduced | INARI MED INC (NARI) | 3.8% | 2.2% | −1.6 pts | −110K sh | −37% |
| New | KARYOPHARM THERAPEUTICS INC (KPTI) | — | 1.2% | +1.2 pts | +1.93M sh | new |
| Increased | ESTABLISHMENT LABS HLDGS INC (ESTA) | 3.1% | 4.8% | +1.7 pts | +84,796 sh | +26% |
| Reduced | SAREPTA THERAPEUTICS INC (SRPT) | 2.9% | 2.5% | −0.4 pts | −42,251 sh | −28% |
| Reduced | INSPIRE MED SYS INC (INSP) | 3.1% | 3.6% | +0.5 pts | −20,000 sh | −20% |
| Reduced | BOSTON SCIENTIFIC CORP (BSX) | 4.7% | 5.0% | +0.2 pts | −100K sh | −14% |
| Reduced | DEXCOM INC (DXCM) | 2.1% | 2.4% | +0.3 pts | −29,920 sh | −20% |
| Reduced | CHARLES RIV LABS INTL INC (CRL) | 6.9% | 7.8% | +0.9 pts | −2,000 sh | −1% |
| Reduced | 908 DEVICES INC (MASS) | 2.6% | 1.2% | −1.4 pts | −25,269 sh | −3% |
| Reduced | STEREOTAXIS INC (STXS) | 0.5% | 0.6% | +0.1 pts | −25,490 sh | −2% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 63.5% of the equity book
Changes in the top 10 this quarter: ICLR entered · UHS entered · COO entered · SGRY entered · GILD entered · RGEN entered · ESTA entered · CI left · NBIX left · HQY left · ACHC left · GH left · HCA left · NARI left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | ICON PLC (ICLR) | 2.7% | 7.8% | Entered the top 10 |
| 2 | CHARLES RIV LABS INTL INC (CRL) | 6.9% | 7.8% | |
| 3 | UNIVERSAL HLTH SVCS INC (UHS) | 0.0% | 7.6% | Entered the top 10 |
| 4 | COOPER COS INC (COO) | 0.0% | 7.3% | Entered the top 10 |
| 5 | SURGERY PARTNERS INC (SGRY) | 2.2% | 6.4% | Entered the top 10 |
| 6 | GILEAD SCIENCES INC (GILD) | 0.0% | 5.7% | Entered the top 10 |
| 7 | SANOFI (SNY) | 6.0% | 5.6% | |
| 8 | REPLIGEN CORP (RGEN) | 3.3% | 5.4% | Entered the top 10 |
| 9 | BOSTON SCIENTIFIC CORP (BSX) | 4.7% | 5.0% | |
| 10 | ESTABLISHMENT LABS HLDGS INC (ESTA) | 3.1% | 4.8% | Entered the top 10 |
| — | CIGNA CORP NEW (CI) | 6.9% | 3.6% | Left the top 10 |
| — | NEUROCRINE BIOSCIENCES INC (NBIX) | 6.6% | 2.1% | Left the top 10 |
| — | HEALTHEQUITY INC (HQY) | 5.2% | 0.0% | Left the top 10 |
| — | ACADIA HEALTHCARE COMPANY IN (ACHC) | 4.8% | 3.0% | Left the top 10 |
| — | GUARDANT HEALTH INC (GH) | 4.6% | 0.0% | Left the top 10 |
| — | HCA HEALTHCARE INC (HCA) | 4.5% | 0.0% | Left the top 10 |
| — | INARI MED INC (NARI) | 3.8% | 2.2% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).